Splash Begins Expansion Phase of SPL-108 Trial for Ovarian Cancer Patients
News
Splash Pharmaceuticals has successfully completed the safety stage of its Phase 1 trial testing a combination of SPL-108 and chemotherapy in platinum-resistant ovarian cancer patients, the company announced in a press release. Taking ... Read more